Bioporto A/S
CSE:BIOPOR

Watchlist Manager
Bioporto A/S Logo
Bioporto A/S
CSE:BIOPOR
Watchlist
Price: 1.466 DKK 2.23% Market Closed
Market Cap: 629.9m DKK

P/E
Price to Earnings

-10.3
Current
-10.2
Median
21.6
Industry
Lower than median
Lower than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E
-10.3
=
Market Cap
629.9m DKK
/
Net Income
-61.3m DKK
Earnings Growth PEG
DK
Bioporto A/S
CSE:BIOPOR
Average P/E: 84.2
Negative Multiple: -10.3
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -173 291 N/A N/A
US
Abbvie Inc
NYSE:ABBV
89.2
88%
1
US
Amgen Inc
NASDAQ:AMGN
41.5
44%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
287.5
185%
1.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -245.6 N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -493 N/A N/A
AU
CSL Ltd
ASX:CSL
27.6
16%
1.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.6
11%
1.5
US
S
Seagen Inc
F:SGT
Negative Multiple: -57.1 N/A N/A
NL
argenx SE
XBRU:ARGX
43
19%
2.3

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/E
-8.1
2-Years Forward
P/E
-7.3
3-Years Forward
P/E
N/A